Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CSNK2B encodes the beta subunit of casein kinase II, a ubiquitous protein kinase which regulates metabolic pathways, signal transduction, transcription, translation, and replication. Additionally we are shipping Casein Kinase 2, beta Proteins (28) and Casein Kinase 2, beta Kits (15) and many more products for this protein.
Showing 10 out of 164 products:
Human Polyclonal CSNK2B Primary Antibody for EIA, WB - ABIN4620507
Schwartz, Intine, Maraia: CK2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5'-terminal oligopyrimidine mRNA metabolism. in Molecular and cellular biology 2004
Show all 3 references for ABIN4620507
Human Polyclonal CSNK2B Primary Antibody for WB - ABIN391101
Lim, Tiu, Li, Qi: Direct regulation of microtubule dynamics by protein kinase CK2. in The Journal of biological chemistry 2004
a functional analysis using rBmCK2alpha and beta subunits of Drosophila melanogaster CK2 (show CSNK2A1 Antibodies) revealed that a difference in the C-terminal amino acid of the CK2beta subunit influenced the phosphorylation activity of rBmCK2alpha.
Data suggest that cryptochromes mediate periodic binding of Ck2b (casein kinase 2beta) to Bmal1 (aryl hydrocarbon receptor nuclear translocator-like (show ARNTL Antibodies) protein) and thus inhibit Bmal1 (show ARNTL Antibodies)-Ser90 phosphorylation by Ck2a (show CSNK2A1 Antibodies) (casein kinase 2alpha). [SYNOPSIS]
Data suggest that cryptochromes (Cry1 (show CRY1 Antibodies) and Cry2 (show CRY2 Antibodies)) mediate periodic binding of Ck2b (casein kinase 2beta) to Bmal1 (aryl hydrocarbon receptor nuclear translocator-like (show ARNTL Antibodies) protein) and thus inhibit Bmal1 (show ARNTL Antibodies)-Ser90 phosphorylation by Ck2a (show CSNK2A1 Antibodies) (casein kinase 2alpha).
AMPKalpha (show GRK4 Antibodies) signalling suppresses EMT (show ITK Antibodies) and secretion of chemokines in renal tubular epithelia through interaction with CK2beta to attenuate renal injury.
CK2 (show CSNK2A1 Antibodies) is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and may have role in malignant B-cell growth.
we propose that Foxc2 (show FOXC2 Antibodies) is functionally maintained in the cytoplasm of normal epithelial cells by CK2alpha/alpha'-mediated phosphorylation at serine 124, which is dependent on proper targeting of the holoenzyme via the CK2b regulatory subunit.
Asymmetric alpha2beta2 tetramers of casein kinase 2 are organized in trimeric rings that correspond to inactive forms of the enzyme. The new crystal structures presented here reveal the symmetric architecture of the isolated active tetramers.
ARKL1 binds CK2beta through the KSSR motif and this involves a polyserine sequence resembling the CK2beta binding sequence in EBNA1 (show EBNA-1 Antibodies).
CK2alpha' exhibits a striking preference for caspase-3 (show CASP3 Antibodies) phosphorylation in cells as compared to CK2alpha and that CK2beta exhibits the capacity to abolish caspase-3 (show CASP3 Antibodies) phosphorylation
The study identifies casein kinase 2 as an NRF1 (show NFE2L1 Antibodies)-binding protein and finds that the knockdown of casein kinase 2 enhances the Nrf1 (show NFE2L1 Antibodies)-dependent expression of the proteasome subunit genes.
Data indicate that protein S phosphorylation by casein kinase 1 (CK1 (show CSNK1A1 Antibodies)) and casein kinase 2 (CK2 (show CSNK2A1 Antibodies)) increased activated proten C cofactor activity.
These data suggest that CK2 is a negative regulator of BMP signaling and osteoblast differentiation.
Data suggest that CK2beta appears to play an essential and uncompensated role in central nervous system development.
Data show that casein kinase 2beta interacts specifically with Tctex4 both in a yeast two-hybrid system and in an in vitro interaction assay.
there is a functional link between S6K1 (show RPS6KB1 Antibodies) II and CK2 (show CSNK2A1 Antibodies) signaling, which involves the regulation of S6K1 (show RPS6KB1 Antibodies) II nuclear export by CK2 (show CSNK2A1 Antibodies)-mediated phosphorylation of Ser (show SIGLEC1 Antibodies)-17
CK2 (show CSNK2A1 Antibodies) can inhibit G protein-coupled receptor (show GPR34 Antibodies) action by enabling faster receptor internalization, possibly through a direct association with Galpha (show SUCLG1 Antibodies)(s)
These data demonstrate that BoHV-1 VP22 interacts with both CK2 (show CSNK2A1 Antibodies) and US3, and that CK2 (show CSNK2A1 Antibodies) is the major kinase phosphorylating VP22, with US3 playing a minor role.
CK2 (show CSNK2A1 Antibodies)-activated phosphorylation cascade controlling PACS-1 (show PACS1 Antibodies)- and GGA3 (show GGA3 Antibodies)-mediated CI-MPR (show IGF2R Antibodies) sorting, is reported.
The CK2alpha/beta complex stimulates Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signalling, and the physical interaction of CK2beta with PAPC (show PCDH8 Antibodies) antagonizes this activity.
Structure of the regulatory subunit of CK2 in the presence of a p21WAF1 peptide
This gene encodes the beta subunit of casein kinase II, a ubiquitous protein kinase which regulates metabolic pathways, signal transduction, transcription, translation, and replication. The enzyme is composed of three subunits, alpha, alpha prime and beta, which form a tetrameric holoenzyme. The alpha and alpha prime subunits are catalytic, while the beta subunit serves regulatory functions. The enzyme localizes to the endoplasmic reticulum and the Golgi apparatus.
casein kinase 2 beta subunit
, CK II beta
, casein kinase II subunit beta
, Casein kinase II beta subunit
, alternative name: G5a, phosvitin
, protein G5a
, casein kinase II, beta subunit
, Csnk2b splicing isoform 662
, casein kinase 2, beta subunit
, casein kinase II beta subunit
, casein kinase II b subunit splicing isoform 666
, casein kinase II b subunit splicing isoform 663
, chimera Csnk2b-Ly6g5b splicing isoform 1239
, Beta subunit of casein kinase II